---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-021078"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:03:04.638573+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma raises $3.2M in registered direct offering; issues warrants at $4.35 per share

## Summary
- Gross proceeds of ~$3.2M from sale of 740,000 shares at $4.35/share in registered direct offering.
- Concurrent private placement of 740,000 warrants exercisable at $4.35, five-year term.
- Closing expected on or about May 23, 2024, subject to customary conditions.
- Roth Capital Partners acted as exclusive placement agent; fees and expenses will be deducted.
- Net proceeds to be used for general corporate purposes.

## SEC filing metadata
- accession: 0001493152-24-021078
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000149315224021078/0001493152-24-021078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000149315224021078/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-021078
- JSON: https://secwatch.observer/filing/0001493152-24-021078.json
- Plain text: https://secwatch.observer/filing/0001493152-24-021078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.